HKEX: 1177 - Sino Biopharmaceutical Limited

Yield per half year: -0.346%
Dividend yield: +2.83%
Sector: Healthcare

Reporting Sino Biopharmaceutical Limited

Reports

IFRS
Reporting Annual Quarterly
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Финансовый отчет link link link link link link link link link link


Capitalization

IFRS
Reporting Annual Quarterly
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 LTM 5 year average CAGR 5
Капитализация, млрд ¥
519.78 231.4 325.47 426.57 248.4 257.15 134.08 83.61 70.08 59.04
Выручка, млрд ¥
12.18 14.17 14.82 20.89 24.23 23.65 26.86 25.41 26.2 26.2
Чистая прибыль, млрд ¥
1.49 1.71 2.17 9.05 2.71 2.77 14.61 4.42 2.33 2.33
EV, млрд ¥
518.96 230.68 324.24 423.31 245.04 260.25 129.01 80.3 56.92 57.21
EBIT, млрд ¥
1.82 2.38 2.89 3.27 4.57 5.25 4.3 4.23 5.91 5.95
EBITDA, млрд ¥
2.68 3.24 3.61 5.75 6.72 5.96 18.88 6.83 7.03 7.26
Баланс стоимость, млрд ¥
6.58 7.9 9.21 29.21 31.11 16.75 30.29 29.75 30.47 30.47
FCF, млрд ¥
0.7987 2.16 2.27 3.4 3.59 3.47 3.47 4.56 4.36 4.36
Операционный денежный поток, млрд ¥
1.92 3.09 3.73 5.09 5.32 5.33 5.37 6.27 6.07 6.07
Операционная прибыль, млрд ¥
2.38 2.89 3.27 4.57 5.25 4.3 5.25 5.91 5.44 5.79
Операционные расходы, млрд ¥
7.08 8.33 8.46 12.12 14.06 19.34 22.52 14.97 15.42 20.41
CAPEX, млрд ¥
0.4357 0.9352 1.46 1.69 1.73 1.86 1.71 1.71 1.7 1.7


Balance sheet

IFRS
Reporting Annual Quarterly
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 LTM 5 year average CAGR 5
Наличность, млрд ¥
2.27 3.76 4.19 6.68 11.91 11.26 10.57 8.65 9.45 9.45
Short Term Investments ¥
2.41 2.53 3.59 2 1.58 4.22 4.66 8.27 4.67 4.67
Long term investments ¥
1.26 1.79 1.85 1.41 1.78 1.07
Total Receivables ¥
1.58 3.09 2.74 3.87 3.34 3.04 3.28 4.64 4.6 3.78
Total Current Assets ¥
8.32 12.73 13.78 18.54 24.91 22.79 23.5 25.93 23.81 23.81
Чистые активы, млрд ¥
2.25 2.69 3.48 5.8 8.21 8.39 8.52 9.25 25.93 9.25
Активы, млрд ¥
13.8 18.39 20.94 49.78 58.3 47.21 60.54 64.06 63.6 63.6
Short Term Debt ¥
1.19 1.37 0.7413 2.91 0.6667 1.55 0.1361 9.72 11.21 11.14
Long Term Debt ¥
0.2596 1.68 2.21 0.5071 7.88 12.8 5.37 4.26 1.07 1.07
Задолженность, млрд ¥
5.06 7.7 8.32 12.23 18.01 24.79 30.25 26.12 25.43 25.43
Чистый долг, млрд ¥
-0.8248 -0.717 -1.24 -3.26 -3.36 2.66 1.16 5.33 3.13 2.76
Долг, млрд ¥
1.45 3.05 2.95 3.41 8.55 14.36 5.5 13.98 12.58 14.12
Interest income ¥
0.2082 0.2208 0.3311 0.0934 0.1186 0.194 13.32 0.592 0.1867
Расходы на обслуживание долга ¥
0.1873 0.5695 0.1533 0.23 0.3234 0.3086 0.3877 0.4952 0.4952
Чист. проц. доходы, млрд ¥
-0.0395 0.0051 0.0095 0.0278 -0.1294 -0.1466 -0.2376 -0.3086 0.2046
Goodwill ¥
0.0886 0.0927 0.099 0.0889 13.9 13.9 0.0889 0.6479 0.6626 0.6805
Амортизация, млрд ¥
0.2075 0.2959 0.3531 0.3434 1.18 1.47 1.65 0.9926 0.9244 1.07
Себестоимость, млрд ¥
2.72 2.95 3.09 4.2 4.93 5.18 5.33 5.12 4.99 4.99
Товарно материальные запасы ¥
0.7956 0.8946 0.9188 1.21 1.66 1.88 1.94 2.33 1.99 1.99


Share

IFRS
Reporting Annual Quarterly
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM 5 year average CAGR 5
EPS 0.31 0.17 0.19 0.18 0.17 0.16 0.71 0.2323 0.1255 0.124
Цена акции ао 31.19 7.74 16.35 7.5 5.46 4.57 3.47 3.22 2.88 2.88
Число акций ао, млн 18873.49 18873.49 18873.49 18873.49 18873.49 18861.5 18839.59 19017.2 18575.08 18801.22
FCF/акцию 0.0423 0.1142 0.1204 0.1802 0.1902 0.1838 0.1843 0.2398 0.2348 0.232


Efficiency

IFRS
Reporting Annual Quarterly
2012 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % 22.64 21.67 23.57 30.97 8.7 16.55 48.23 14.71 7.74 7.74 8.15
ROA, % 10.79 9.32 10.37 18.17 4.64 5.87 24.13 7.09 3.65 3.65 5.11
ROIC, % 18.97 17.79 21.64 19.28 21.55 29.91 8.89 12.73 43.44 11.55
ROS, % 14.65 43.31 11.17 11.72 54.38 17.38 8.9 8.9 8.9 8.9 7.36
ROCE, % 25.87 27.24 27.02 25.92 12.18 13.04 19.2 13.96 13.45 14.52 5.48
Рентаб EBITDA, % 21.98 22.88 24.38 27.52 27.72 25.2 70.29 26.88 26.82 25.24 6.06
Ebit margin, % 23.97 20.67 70.21 23.25 22.72
Чистая рентаб, % 12.22 12.09 14.65 43.31 11.17 11.72 54.38 17.38 8.9 8.9 7.37
Operation Margin, % 22.06 21.89 21.67 18.2 19.55 23.25 20.76 22.08 22.08 22.08 9.85
Доходность FCF, % 0.2986 0.1537 0.9316 0.6982 0.7974 1.45 1.35 2.59 5.45 6.22


Coefficients

IFRS
Reporting Annual Quarterly
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
348.98 135.07 149.92 47.15 91.77 92.8 9.18 16.97 23.07 23.35 22.50
P/BV
79 29.27 35.34 14.6 7.98 15.35 4.43 1.98 1.41 1.43 2.99
P/S
42.66 16.33 21.96 20.42 10.25 10.87 4.99 2.95 2.05 2.08 9.92
P/FCF
143.23 125.4 69.18 74.19 38.61 18.34 16.07 13.53 13.53 13.53 6.18
E/P
0.0067 0.0212 0.0109 0.0108 0.109 0.0304 0.0333 0.0395 0.0395 0.0395 0.04
EV/EBITDA
193.78 71.16 89.75 73.63 36.48 43.67 6.83 11.75 8.1 11.92 -5.04
EV/Ebit
31.02 24.95 4.68 13.59 9.56 0 0 0
EV/S
21.88 20.27 10.11 11.01 4.8 3.16 2.17 2.18 2.18 2.18 46.67
EV/FCF
142.69 124.44 68.24 75.08 37.15 17.61 13.05 13.11 13.11 13.11 16.02
Debt/EBITDA
0.8169 0.5936 1.27 2.41 0.2914 2.05 1.79 1.94 1.94 1.94 0.72
Netdebt/Ebitda
-0.3424 -0.5676 -0.5001 0.4459 0.0617 0.7798 0.4452 0.38 0.38 0.38 -0.64
Debt/Ratio
0.141 0.0686 0.1467 0.3041 0.0909 0.2182 0.1978 0.222 0.222 0.222 0.10
Debt/Equity
0.3205 0.1168 0.2749 0.8572 0.1816 0.47 0.4128 1.53 1.53 1.53 0.96
Debt/Net Income
1.36 0.3772 3.16 5.18 0.3766 3.17 5.39 6.06 6.06 6.06 1.14
Бета
-1.34 0.6168 -1.25 -1.25 -0.84
Индекс Альтмана
18.39 10.27 4.51 9.43 8.86 3.57 3.07 3.94 3.97 3.97 5.63


Dividends

IFRS
Reporting Annual Quarterly
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM Industry average 5 year average CAGR 5
Див.выплата, млрд
0.2483 0.3982 0.45 0.7103 0.8197 1.19 0.9385 0.6327 0.6327 0.4692
Дивиденд
0.0267 0.0311 0.04 0.04 0.0533 0.04 0.1 0.08 0.06 0.06
Див доход, ао, %
0.2176 0.1805 0.1769 0.3038 0.3912 0.5621 3.25 2.6 1.55 2.83 2.64
Дивиденды / прибыль, %
16.67 23.24 20.73 7.85 30.28 42.84 6.42 28.7 27.13 27.13 18.57


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual
2023 2024 CAGR 5
Персонал, чел
26272 26079